(Q38128370)

29 August 2017

title

Radiofrequency ablation for hepatocellular carcinoma. (English)

1 reference

29 August 2017

Hiroki Nishikawa

1

1 reference

29 August 2017

Toru Kimura

series ordinal

2

1 reference

29 August 2017

Ryuichi Kita

series ordinal

3

1 reference

29 August 2017

Yukio Osaki

series ordinal

4

1 reference

29 August 2017

publication date

12 August 2013

1 reference

International Journal of Hyperthermia

29 August 2017

published in

1 reference

29 August 2017

volume

29

1 reference

29 August 2017

issue

6

1 reference

29 August 2017

page(s)

558-568

1 reference

Primary liver cancer: worldwide incidence and trends

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

The global epidemiology of hepatocellular carcinoma: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Epidemiology of viral hepatitis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Surgery for small liver cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Single HCC smaller than 2 cm: surgery or ablation?: surgeon's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Outcomes and recurrence of initially resectable hepatocellular carcinoma meeting milan criteria: Rationale for partial hepatectomy as first strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Cryoablation for liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Percutaneous ethanol injection therapy of hepatoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Current status of molecularly targeted therapy for hepatocellular carcinoma: clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Complete response of advanced hepatocellular carcinoma with multiple lung metastases treated with sorafenib: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Complications of radiofrequency coagulation of liver tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Local ablation therapy for hepatocellular carcinoma: current status and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: comparison with enhanced CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Radiofrequency tumor ablation: principles and techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Microwave liver ablation: influence of hepatic vein size on heat-sink effect in a porcine model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Radiofrequency ablation versus surgical resection for single nodule hepatocellular carcinoma: long-term outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Percutaneous radiofrequency ablation with cooled electrodes combined with hepatic arterial balloon occlusion in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Loco-regional treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Percutaneous radiofrequency ablation of hepatocellular carcinoma on cirrhosis: state of the art and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Percutaneous ultrasound-guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Efficacy of contrast-enhanced ultrasonography in radiofrequency ablation for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Lyso-thermosensitive liposomal doxorubicin: an adjuvant to increase the cure rate of radiofrequency ablation in liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Diagnostic utility of interleukin-6 (IL-6) for primary bile duct cancer and changes in serum IL-6 levels following photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Percutaneous cryoablation of small hepatocellular carcinomas using a 17-gauge ultrathin probe.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Effectiveness, safety, and local progression after percutaneous laser ablation for hepatocellular carcinoma nodules up to 4 cm are not affected by tumor location

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Severe Complications of Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: An Analysis of 3,891 Ablations in 2,614 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

Newly Developed Novel Ultrasound Technique, Defect Reperfusion Ultrasound Imaging, Using Sonazoid in the Management of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

In vivo determination of a modified heat capacity of small hepatocellular carcinomas prior to radiofrequency ablation: correlation with adjacent vasculature and tumour recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02656736.2013.821528

10.3109/02656736.2013.821528

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference